Skip to Main Content

Rummana Aslam, MBBS

Associate Professor of Orthopaedics and Rehabilitation; Director, Wound Care; Affiliated Faculty, Yale Institute for Global Health; Program Director Yale Chronic Wound Care and Regenerative Medicine Fellowship, Orthopaedics and Rehabilitation; Chief, Physical Medicine and Rehabilitation, Orthopaedics and Rehabilitation; Core Faculty, Podiatric Medicine and Surgery Residency Program; Founder Physical Medicine and Rehabilitation Residency Program , Orthopaedics and Rehabilitation; Co-Lead Yale 3D Avascular Necrosis and Osteonecrosis Program, Dept Clinical: Orthopaedics & Rehabilitation

Contact Information

Rummana Aslam, MBBS

Office Location

Mailing Address

  • Orthopaedics & Rehabilitation

    P.O. Box 208071

    New Haven, CT 06520-8071

    United States

Research Summary

Current research projects

A. Digitalization of the Physical Performance Test and Training

The digitalized version of the Physical Performance Test, measures the movements of the human body with the help of sensors. The two types of sensors used for these measurements are the Inertial Measurement Unit (IMU) and force sensors. Digitizing the conventional test will be used to obtain objective and continuous data from patients undergoing acute rehabilitation and compare to conventional methods. The goal is to increase the accuracy of the assessment of physical performance Computer software will be developed to evaluate the test score of the patient.

B. Rehabilitation Device for and Mirror Therapy

The primary objective of this study is to compare the MiraTT hand therapy device mirror therapy to conventional mirror therapy. In conventional mirror therapy the affected hand does not actually. In MiraTT mirror therapy the digits of the affected hand actually move and mirror the movement of the digits of the normal hand

C. The Automated Test of Embodied Cognition (ATEC) uses motion capture technology and machine learning algorithms to assess cognition in action. Unlike conventional neuropsychological assessments that rely on paper and pencil and computer tasks to measure attention, memory, and executive function, ATEC captures those abilities using cognitively demanding physical tasks. Measuring cognition in action is a paradigm shift, in keeping with contemporary neuroscience, and is especially relevant for population with cognitive disordersThe aims are: 1) Algorithm development for scoring, following procedures proven effective in our prototype. Data will include motion capture data that hasalready been collected or is being collected in 2 current VA clinical trials and motion capture data from participants with specific cognitive disorders to be recruited in this proposed study. These include patients with mild to moderate cases of Stroke, Dementia (all cause), mild TBI, Movement Disorders and chronic Alcohol Use Disorder. 2) Improvements in user interface of the computer application along with adaptations for VA Telehealth. This will involve improving the user interface, embedding the scoring algorithms into the interface, redoing some of the video instructions, and developing, and then qualitatively assessing, the Telehealthversion. 3) Develop report templates with scores, interpretation, and treatment recommendations in a version suitable for clinicians and a version for patients and caregivers.The deliverables at the end of 3 years include 1) an easily transferable technology (computer application) that provides an automated high-fidelity administration of ATEC and automated scoring of patient performance.2) Test reports with easily readable graphics and interpretation of findings that are automatically produced. 3) A Telehealth version specific to the VA National TeleNeurology Program (NTNP).

D. Botulinum Toxin-A for Hidradenitis Suppurativa. Randomized double blinded clinical trial

The primary objective of this Phase IV study is to determine if Botulinum Toxin-A induces regression, remission, or relapse of hidradenitis suppurativa lesions.

The secondary objective of this investigation is to determine if Botulinum Toxin-A improves patient-reported quality of life outcomes in hidradenitis suppurativa


E . Effect of the Duration of Hyperbaric Oxygen Treatment on Femoral Head Avascular Necrosis

Primary Objective

The primary objective of this study is to determine whether the length of hyperbaric oxygen therapy treatment sessions (3 weeks versus 6 weeks), combined with core decompression with autologous bone marrow aspirate concentrate effect the incidence of femoral head collapse of patients with femoral head avascular necrosis.

Secondary Objective

The secondary objective of this study is to determine whether the length of hyperbaric oxygen therapy treatment sessions affect patient pain and function in patients with femoral head avascular necrosis.


Extensive Research Description

My research interest focuses on the following areas

1. Wound repair and regeneration

2. New innovative applications of hyperbaric oxygen therapy

3. Quantification of physical performance and cognition

Research Interests

Patient Outcome Assessment; Analytical, Diagnostic and Therapeutic Techniques and Equipment

Public Health Interests

Clinical Trials

Selected Publications